Prime-time for the cure of inherited retinal diseases by CRISPR-based precision genome editing

The objective of the project is to apply the gene editing tool - Pirme Editing (PE) - based on the Nobel Prize winning CRISPR/Cas9 for the treatment of the genetically heterogeneous disease group of Inherited retinal dystrophies (IRDs). The project is implemented by the grantee as a postdoc-project at the Laboratory for Experimental Retinal Genome Therapy at the Department of Biomedicine, University of Aarhus and at the Department of Ophthalmology at  Aarhus University Hospital - the first two years on full time at the Nuffield Laboratory of Ophthalmology, Department of Clinical Neurosciences at Oxford Universitet.